甲氧西林耐药金黄色葡萄球菌(methicillin-resistantStaphylococcus aureus,MRSA)是临床上一类重要的耐药菌,MRSA感染可造成患者死亡率上升、住院天数和医疗费用增加等,应受到高度重视.临床上,万古霉素依然是抗MRSA感染的主要药物,但多种抗MRSA感染新药的问世,使治疗有了更多选择.MRSA传播和感染预防的策略分为基本策略和特殊策略.%Methicillin-resistant Staphylococcus aureus (MRSA) is a common pathogen for hospital aquired infection. Great emphasis on MRSA associated infections is intimately related to higher mortality, more length of stay and higher costs, etc. There are more selective drugs since there come a lot of new anti-MRSA drugs, although Vancomycinis still the main drug for MRSA associated infections. Prevention strategies for MRSA associated infections are divided into basic strategies and special strategies.
展开▼
